Jane Street’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Sell |
504,342
-334,016
| -40% | -$14.4M | ﹤0.01% | 475 |
|
|
2025
Q1 | $29M | Buy |
838,358
+173,434
| +26% | +$6M | 0.01% | 327 |
|
|
2024
Q4 | $18.2M | Buy |
664,924
+140,563
| +27% | +$3.86M | ﹤0.01% | 472 |
|
|
2024
Q3 | $13.4M | Sell |
524,361
-192,824
| -27% | -$4.91M | ﹤0.01% | 615 |
|
|
2024
Q2 | $18.2M | Buy |
717,185
+487,609
| +212% | +$12.4M | ﹤0.01% | 690 |
|
|
2024
Q1 | $7.1M | Sell |
229,576
-6,854
| -3% | -$212K | ﹤0.01% | 1029 |
|
|
2023
Q4 | $9.54M | Sell |
236,430
-80,852
| -25% | -$3.26M | ﹤0.01% | 963 |
|
|
2023
Q3 | $8.37M | Sell |
317,282
-27,412
| -8% | -$723K | ﹤0.01% | 966 |
|
|
2023
Q2 | $5.93M | Buy |
344,694
+184,682
| +115% | +$3.18M | ﹤0.01% | 1360 |
|
|
2023
Q1 | $2.65M | Buy |
160,012
+105,954
| +196% | +$1.76M | ﹤0.01% | 1740 |
|
|
2022
Q4 | $412K | Buy |
54,058
+33,883
| +168% | +$258K | ﹤0.01% | 3619 |
|
|
2022
Q3 | $201K | Sell |
20,175
-60,373
| -75% | -$601K | ﹤0.01% | 4584 |
|
|
2022
Q2 | $731K | Buy |
80,548
+58,056
| +258% | +$527K | ﹤0.01% | 3136 |
|
|
2022
Q1 | $228K | Sell |
22,492
-149,845
| -87% | -$1.52M | ﹤0.01% | 4591 |
|
|
2021
Q4 | $2.87M | Buy |
172,337
+133,197
| +340% | +$2.22M | ﹤0.01% | 1534 |
|
|
2021
Q3 | $1.83M | Buy |
39,140
+28,278
| +260% | +$1.33M | ﹤0.01% | 1926 |
|
|
2021
Q2 | $662K | Buy |
10,862
+2,050
| +23% | +$125K | ﹤0.01% | 3104 |
|
|
2021
Q1 | $543K | Sell |
8,812
-36,478
| -81% | -$2.25M | ﹤0.01% | 3252 |
|
|
2020
Q4 | $3.22M | Buy |
45,290
+15,307
| +51% | +$1.09M | ﹤0.01% | 1024 |
|
|
2020
Q3 | $1.13M | Buy |
29,983
+20,506
| +216% | +$769K | ﹤0.01% | 1680 |
|
|
2020
Q2 | $309K | Buy |
+9,477
| New | +$309K | ﹤0.01% | 3016 |
|